BUTYROSE
Slow-release sodium butyrate LSC MicroCaps - EU patent 2352386. Food for special medical purposes based on microencapsulated sodium butyrate. The patented microcapsule formulation with LSC barrier-effect technology is used because sodium butyrate is a very active molecule but with a high degree of dissociation (pKa 4.82), which without protection would not reach the colon/rectum. Indicated for the dietary management of people with colon disorders with altered trophism of the intestinal mucosa.
Ingredients | | per 100 g | per 3 capsules |
Microencapsulated sodium butyrate (hydrogenated palm oil, sodium butyrate, bulking agent: E 516, flavourings, coating agent: E 477) | 33.5 g | 600 mg |
| Other ingredients: vegetable capsule (coating agent: E 464, colour: E 171). |
Directions for use Take 1-3 capsules a day with meals; if you have difficulty swallowing, the capsule can be opened and its contents taken dispersed in drinks or semi-solid foods (water, milk, fruit juice, yoghurt, soups, etc.). Do not cook it or expose it to temperatures above 40°/45°C, so as not to alter the patented protection of the sodium butyrate. There are no time limits on the duration of treatment.
Contraindications No hypersensitivity reactions or interactions with other medicines are known. In case of adverse symptoms, consult a doctor.
Storage Store in a cool, dry place below 25°C, away from heat sources and direct sunlight. The best-before date refers to the product correctly stored in intact packaging.
Nutritional information | | per 100 g | 3 capsules |
| Energy | 572 kcal 2368 kJ | 10 kcal 42 kJ |
| Protein | 15.1 g | 0.27 g |
| Carbohydrate | 14.3 g | 0.26 g |
| Fat | 50.5 g | 0.9 g |
Pack size Pack of 15 capsules.